Factor This Power Engineering
Live Events
DTECH® Events
POWERGENâ¢
Calendar
Webinars
Podcasts
Contribute Content
Solar
Community
Residential
Utility Scale
Wind Power
Offshore
Turbines & Equipment
Power Grid
Distribution
Grid Modernization
Microgrids
Outage Management
Smart Grids
Transmission
Hydropower
Dams & Civil Structures
Small Hydropower
Technology & Equipment
Tidal & Wave Energy
Energy Storage
Battery
Long Duration
Pumped Storage
Business
Finance
Policy & Regulation
Project Development
Tariffs
Electric Vehicles
EV Charging
Vehicle to Grid
Subscribe
Solar
Community
Residential
Utility Scale
Wind Power
Offshore
Turbines & Equipment
Power Grid
Distribution
Grid Modernization
Microgrids
Outage Management
Transmission
Smart Grids
Hydropower
Dams & Civil Structures
Small Hydro
Technology & Equipment
Tidal & Wave Energy
Energy Storage
Battery
Long Duration
Pumped Storage
Business
Finance
Policy & Regulation
Electric Vehicles
EV Charging
Vehicle to Grid
Factor This: Power Engineering
Live Events
DISTRIBUTECH®
Podcasts
Webinars
Calendar
Contribute Content
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Hydroworld Market Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Articles published by Pacira BioSciences
< Previous
1
2
3
Next >
Pacira BioSciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
December 03, 2025
From
Pacira BioSciences
Via
GlobeNewswire
Tickers
PCRX
Pacira BioSciences Announces Results From 12-Month Pilot Study Demonstrating Favorable Safety and Significant Improvements in Pain With iovera° Compared to Radiofrequency Ablation in Chronic Low Back Pain
December 02, 2025
From
Pacira BioSciences
Via
GlobeNewswire
Tickers
PCRX
Pacira BioSciences Files EXPAREL® Patent Infringement Lawsuits Against The WhiteOak Group and Qilu Pharmaceutical
November 26, 2025
From
Pacira BioSciences
Via
GlobeNewswire
Tickers
PCRX
Pacira BioSciences to Participate in Fireside Chat at Two Upcoming Healthcare Conferences
November 11, 2025
From
Pacira BioSciences
Via
GlobeNewswire
Tickers
PCRX
Pacira BioSciences Reports Third Quarter 2025 Financial Results; Increases Full-year Gross Margin Guidance
November 06, 2025
From
Pacira BioSciences
Via
GlobeNewswire
Tickers
PCRX
Pacira BioSciences Concludes Patient Enrollment in Part A of Phase 2 Study Evaluating Safety and Efficacy of PCRX-201 for the Treatment of Osteoarthritis of the Knee
November 05, 2025
From
Pacira BioSciences
Via
GlobeNewswire
Tickers
PCRX
Pacira BioSciences Enters Exclusive License Agreement with AmacaThera for its Novel Long-acting Analgesic for Postsurgical Pain Control
November 04, 2025
From
Pacira BioSciences
Via
GlobeNewswire
Tickers
PCRX
Pacira to Report Third Quarter 2025 Financial Results on Thursday November 6, 2025
October 30, 2025
From
Pacira BioSciences
Via
GlobeNewswire
Tickers
PCRX
Pacira BioSciences Presents Updated Three-Year Data Demonstrating Sustained Efficacy and Safety of PCRX-201 Gene Therapy for Patients with Moderate-to-Severe Osteoarthritis of the Knee
October 28, 2025
From
Pacira BioSciences
Via
GlobeNewswire
Tickers
PCRX
Pacira BioSciences Notified of Abbreviated New Drug Application Filing from Qilu Pharmaceutical (Hainan) Co., Ltd. for EXPAREL®
October 27, 2025
From
Pacira BioSciences
Via
GlobeNewswire
Tickers
PCRX
Pacira BioSciences to Present New Data from Three Real-World Studies with EXPAREL®
October 23, 2025
From
Pacira BioSciences
Via
GlobeNewswire
Tickers
PCRX
Pacira BioSciences Notified of Abbreviated New Drug Application Filing from The WhiteOak Group for EXPAREL®
October 21, 2025
From
Pacira BioSciences
Via
GlobeNewswire
Tickers
PCRX
Pacira BioSciences to Present 3-Year Data Demonstrating Sustained Pain and Function Improvements in Knee Osteoarthritis with Investigational PCRX-201 Gene Therapy
October 20, 2025
From
Pacira BioSciences
Via
GlobeNewswire
Tickers
PCRX
Pacira BioSciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
October 03, 2025
From
Pacira BioSciences
Via
GlobeNewswire
Tickers
PCRX
Pacira BioSciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
September 05, 2025
From
Pacira BioSciences
Via
GlobeNewswire
Tickers
PCRX
Pacira BioSciences Reports Second Quarter 2025 Financial Results
August 05, 2025
From
Pacira BioSciences
Via
GlobeNewswire
Tickers
PCRX
Pacira to Report Second Quarter 2025 Financial Results on Tuesday August 5, 2025
July 24, 2025
From
Pacira BioSciences
Via
GlobeNewswire
Tickers
PCRX
Pacira BioSciences Announces Strategic Collaboration to Significantly Expand ZILRETTA Promotional Efforts
July 22, 2025
From
Pacira BioSciences
Via
GlobeNewswire
Tickers
PCRX
Pacira BioSciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
July 03, 2025
From
Pacira BioSciences
Via
GlobeNewswire
Tickers
PCRX
Pacira BioSciences Debuts Inspiring New Film Highlighting One Patient’s Journey to Pain Relief and Innovation in Care at BIO 2025
June 18, 2025
From
Pacira BioSciences
Via
GlobeNewswire
Tickers
PCRX
Pacira BioSciences Unveils Three-Year Clinical Data Following a Single Local Administration of Investigational Gene Therapy, PCRX-201, in Patients with Moderate-to-Severe Osteoarthritis of the Knee
June 11, 2025
From
Pacira BioSciences
Via
GlobeNewswire
Tickers
PCRX
Pacira BioSciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
June 05, 2025
From
Pacira BioSciences
Via
GlobeNewswire
Tickers
PCRX
Pacira BioSciences Presents New Data on the Effects of Clinical Immunogenicity on Locally Administered PCRX-201 in Patients with Moderate to Severe Osteoarthritis of the Knee
May 15, 2025
From
Pacira BioSciences
Via
GlobeNewswire
Tickers
PCRX
Pacira BioSciences to Participate in Fireside Chat at Two Upcoming Healthcare Conferences
May 14, 2025
From
Pacira BioSciences
Via
GlobeNewswire
Tickers
PCRX
Pacira BioSciences Reports First Quarter 2025 Financial Results
May 08, 2025
From
Pacira BioSciences
Via
GlobeNewswire
Tickers
PCRX
Pacira BioSciences to Present 3-Year Safety and Efficacy Data of PCRX-201 Following Single Intra-Articular Injection for Moderate-to-Severe Knee Osteoarthritis
May 06, 2025
From
Pacira BioSciences
Via
GlobeNewswire
Tickers
PCRX
Pacira BioSciences to Present New Data on Clinical Immunogenicity of Intra-Articular PCRX-201 and Its Implications for Dosing Strategy in Knee Osteoarthritis
May 02, 2025
From
Pacira BioSciences
Via
GlobeNewswire
Tickers
PCRX
Pacira to Report First Quarter 2025 Financial Results on Thursday May 8, 2025
April 29, 2025
From
Pacira BioSciences
Via
GlobeNewswire
Tickers
PCRX
Pacira BioSciences Announces Two-Year Efficacy Data Following a Single Local Administration of PCRX-201 in Patients with Mild to Severe Osteoarthritis of the Knee
April 28, 2025
From
Pacira BioSciences
Via
GlobeNewswire
Tickers
PCRX
Pacira BioSciences to Present 104-Week Efficacy Data Following a Single Local Administration of PCRX-201 for Patients with Mild to Severe Osteoarthritis of the Knee
April 22, 2025
From
Pacira BioSciences
Via
GlobeNewswire
Tickers
PCRX
< Previous
1
2
3
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.